Skip to main content
. 2020 May 5;2020:6076274. doi: 10.1155/2020/6076274

Table 2.

Observed and expected value of each gene polymorphism in RSA patients with or without PCOS and controls by the Hardy-Weinberg equilibrium.

Gene polymorphism RSA with PCOS RSA without PCOS Control
Observed Expected p Observed Expected p Observed Expected p
IL-1β-511C/T (rs16944) CC 26 22.6 >0.05 33 32.5 >0.05 47 46.6 >0.05
CT 27 33.8 28 31.1 67 67.8
TT 16 12.6 9 7.5 25 24.6

IL-6-174G/C (rs1800795) GG 42 39.4 >0.05 43 44.2 >0.05 88 88.8 >0.05
GC 21 26.3 24 23.7 43 41.4
CC 7 4.4 3 3.2 4 4.8

TNF-α-1031T/C (rs1799964) TT 50 50.3 >0.05 44 45.1 >0.05 82 80.5 >0.05
TC 17 16.3 23 23.8 46 49.1
CC 1 1.3 3 3.1 9 7.5

TGFβ1-509T/C (rs1800469) TT 29 29.3 >0.05 30 32.9 >0.05 60 58.0 >0.05
TC 32 31.3 36 30.2 57 61.0
CC 8 8.3 4 6.9 18 16.0